Larson Financial Group LLC Purchases 1,000 Shares of Integer Holdings Co. (NYSE:ITGR)

Larson Financial Group LLC raised its position in shares of Integer Holdings Co. (NYSE:ITGR) by 20,000.0% during the 3rd quarter, HoldingsChannel.com reports. The fund owned 1,005 shares of the medical equipment provider’s stock after acquiring an additional 1,000 shares during the period. Larson Financial Group LLC’s holdings in Integer were worth $131,000 as of its most recent SEC filing.

Several other large investors have also bought and sold shares of the company. Contravisory Investment Management Inc. boosted its position in shares of Integer by 55.9% in the 3rd quarter. Contravisory Investment Management Inc. now owns 223 shares of the medical equipment provider’s stock worth $29,000 after purchasing an additional 80 shares in the last quarter. Huntington National Bank boosted its position in shares of Integer by 8,933.3% in the 3rd quarter. Huntington National Bank now owns 271 shares of the medical equipment provider’s stock worth $35,000 after purchasing an additional 268 shares in the last quarter. Quest Partners LLC boosted its position in shares of Integer by 3,688.9% in the 2nd quarter. Quest Partners LLC now owns 341 shares of the medical equipment provider’s stock worth $39,000 after purchasing an additional 332 shares in the last quarter. GAMMA Investing LLC boosted its position in shares of Integer by 60.9% in the 2nd quarter. GAMMA Investing LLC now owns 375 shares of the medical equipment provider’s stock worth $43,000 after purchasing an additional 142 shares in the last quarter. Finally, Innealta Capital LLC bought a new stake in shares of Integer in the 2nd quarter worth approximately $110,000. 99.29% of the stock is owned by institutional investors.

Analyst Ratings Changes

A number of analysts have recently commented on ITGR shares. Bank of America boosted their price target on Integer from $135.00 to $145.00 and gave the stock a “buy” rating in a research report on Tuesday, October 1st. Benchmark upped their price objective on Integer from $130.00 to $140.00 and gave the company a “buy” rating in a research report on Monday, October 21st. Truist Financial lowered their price objective on Integer from $150.00 to $147.00 and set a “buy” rating on the stock in a research report on Friday, October 25th. Citigroup upped their price objective on Integer from $124.00 to $130.00 and gave the company a “neutral” rating in a research report on Tuesday, October 1st. Finally, KeyCorp upped their price objective on Integer from $139.00 to $144.00 and gave the company an “overweight” rating in a research report on Tuesday, October 15th. One investment analyst has rated the stock with a hold rating and seven have given a buy rating to the company. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $139.75.

Integer Price Performance

NYSE ITGR opened at $140.80 on Friday. The business’s fifty day moving average price is $131.15 and its 200-day moving average price is $124.17. The stock has a market capitalization of $4.72 billion, a price-to-earnings ratio of 43.46, a PEG ratio of 2.01 and a beta of 1.09. The company has a debt-to-equity ratio of 0.67, a current ratio of 3.28 and a quick ratio of 2.09. Integer Holdings Co. has a 1-year low of $84.75 and a 1-year high of $141.27.

Integer (NYSE:ITGR) last released its quarterly earnings results on Thursday, October 24th. The medical equipment provider reported $1.43 earnings per share for the quarter, beating the consensus estimate of $1.36 by $0.07. The firm had revenue of $431.42 million for the quarter, compared to analysts’ expectations of $440.59 million. Integer had a return on equity of 11.63% and a net margin of 6.70%. The company’s revenue was up 8.7% compared to the same quarter last year. During the same period in the prior year, the firm earned $1.27 EPS. On average, equities analysts predict that Integer Holdings Co. will post 5.34 earnings per share for the current year.

Integer Company Profile

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.